Join to View Full Profile
125 Paterson StSte 5200New Brunswick, NJ 08901
Phone+1 732-235-7219
Dr. Salsali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 1998 - 2001
Tehran University of Medical Sciences School of MedicineClass of 1991
Certifications & Licensure
ND State Medical License Current
NJ State Medical License 2008 - 2025
VT State Medical License 2001 - 2012
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbAlevels (STEP-HFpEF DM): a prespecified analysis of...Melanie J Davies, Peter van der Meer, Subodh Verma, Shachi Patel, Khaja M Chinnakondepalli
The Lancet. Diabetes & Endocrinology. 2025-03-01 - 101 citationsImpact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.Jan Biegus, Adriaan A Voors, Sean P Collins, Mikhail N Kosiborod, John R Teerlink
European Heart Journal. 2023-01-01 - 26 citationsRenal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.Adriaan A Voors, Kevin Damman, John R Teerlink, Christiane E Angermann, Sean P Collins
European Journal of Heart Failure. 2022-10-01
Journal Articles
- Empagliflozin Compared with Glimepiride in Metformin‐Treated Patients with Type 2 Diabetes: 208‐Week Data from a Masked Randomized Controlled TrialAfshin Salsali, MD, Diabetes, Obesity and Metabolism
Press Mentions
Empagliflozin Lowers High Blood Pressure, Blood Sugar in DiabeticsJune 23rd, 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
